Condition
PET / CT clinical trials and research
As of November 12, 2026, Find a Trial lists 10 PET / CT clinical trials that are recruiting, at sites in 3 countries (most in China (7), Netherlands (2), Norway (1)). 2 were first registered in the last 30 days. By phase: Phase 2/3 (1). The most active sponsors are The First Affiliated Hospital of Xiamen University (4), Leiden University Medical Center (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 2New in 30 days
- 3Countries
Newest PET / CT clinical trials
All recruiting trials (10)
-
68Ga-XHER2 PET/CT imaging to see HER2 in solid tumors
A noninvasive PET/CT imaging test using 68Ga-XHER2 is being tried to see if it reflects HER2 levels in solid tumors.
-
68Ga-XMFH01 PET/FL imaging to guide prostate cancer surgery
This study tests a new dual-modality imaging probe, 68Ga-XMFH01, to preoperatively detect prostate cancer and guide the surgeon with fluorescence during operations in adults with newly diagnosed prostate cancer.
-
DLL3-targeted PET/CT for detecting neuroendocrine carcinoma
We are testing a DLL3-targeted PET/CT scan to see if it better finds tumors in adults with suspected or confirmed neuroendocrine carcinoma.
-
Making PET-like images from CT to improve lung cancer diagnosis and care
This project will test whether PET-like images generated from routine diagnostic CT scans can help doctors diagnose, stage, and plan treatment for people with non-small cell lung cancer who are having PET-CT and pathology tests.
-
Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinoma
This study uses PET/CT imaging with two tracers to see if they can better stage NPC and predict early response to neoadjuvant immunotherapy in adults with newly diagnosed NPC.
-
18F-FAPI PET/CT and laparoscopy for staging advanced stomach cancer
This trial tests whether an 18F-FAPI PET/CT scan, used with laparoscopy, can better find spread of advanced stomach cancer and help doctors avoid unnecessary surgery.
-
Using 68Ga-grazytracer PET imaging to evaluate immunotherapy in lung cancer
This study is testing if a special type of PET imaging can help doctors see how well immunotherapy is working for patients with stage III non-small cell lung cancer.
-
Evaluating a new imaging method for clear cell renal cell carcinoma
This study is testing a new imaging method using a special probe to see if it can better help doctors diagnose clear cell renal cell carcinoma in Chinese patients compared to the standard imaging method.
-
Using imaging to improve proton therapy for chordomas and chondrosarcomas
This study is testing if using advanced imaging techniques can help improve proton therapy for patients with aggressive bone tumors called chordomas and chondrosarcomas by better targeting the tumors and protecting healthy tissue.
-
Comparing PET/CT imaging methods in multiple myeloma patients
This study is testing whether a new type of PET/CT scan using amino acids gives better information than the standard FDG PET/CT scan for people with multiple myeloma who may need a stem cell transplant.
Related topics
Quick answers
How many PET / CT clinical trials are recruiting right now?
10, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (7 trials), Netherlands (2 trials), Norway (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.